Short Interest in Genus plc (OTCMKTS:GENSF) Rises By 32.9%

Genus plc (OTCMKTS:GENSFGet Free Report) was the target of a large increase in short interest in February. As of February 13th, there was short interest totaling 49,507 shares, an increase of 32.9% from the January 29th total of 37,249 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Genus Price Performance

OTCMKTS:GENSF opened at $37.25 on Wednesday. The stock has a 50 day moving average of $36.27 and a 200-day moving average of $35.43. Genus has a 52 week low of $35.00 and a 52 week high of $37.25.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Genus in a research note on Thursday, November 20th. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy”.

Check Out Our Latest Stock Report on GENSF

About Genus

(Get Free Report)

Genus plc, trading on the OTCMKTS under the symbol GENSF, is a global leader in innovative animal genetics and breeding solutions. The company operates through two primary business segments: ABS and PIC. ABS focuses on bovine genetics, offering dairy and beef cattle semen, advanced reproductive technologies and digital herd management tools. PIC specializes in porcine genetics, providing breeding stock, genetic evaluation services and production support aimed at optimizing growth performance, health and sustainability across the global swine industry.

With origins dating back to its establishment in 1933 as the British Dairy Cattle Breeders’ Society, Genus has expanded through strategic acquisitions and organic growth to build a leading position in animal biotechnology.

Further Reading

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.